📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting protein kinase CK2 in the treatment of cholangiocarcinoma. (2021)

First Author: Jayaraman PS

Attributed to: PRH/HHEX in intrahepatic cholangiocarcinoma, disease progression and response to chemotherapeutics. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.37349/etat.2021.00055

PubMed Identifier: 36045705

Publication URI: http://europepmc.org/abstract/MED/36045705

Type: Journal Article/Review

Volume: 2

Parent Publication: Exploration of targeted anti-tumor therapy

Issue: 5

ISSN: 2692-3114